Home › Scleroderma › New York › New York City
Scleroderma klinische studies in New York City, NY
11 studies voor Scleroderma zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruterenFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RekruterenFase 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruterenFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruterenFase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
RekruterenFase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruterenFase 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RekruterenFase 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
RekruterenFase 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruterenFase 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
RekruterenFase 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekruterenFase 2
- aTyr Investigative Site, New York
Scleroderma studies in andere steden
- Chicago, IL10 studies
- Ann Arbor, MI10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Los Angeles, CA7 studies
- Durham, NC7 studies
- New Orleans, LA6 studies
- Philadelphia, PA6 studies
- Baltimore, MD6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
- Miami, FL4 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.